[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

Year

Day

January 20, 2017
Viewpoint

Benefit-Risk Assessments at the US Food and Drug AdministrationFinding the Balance

Abstract Full Text
free access
JAMA. Published online January 20, 2017. doi:10.1001/jama.2017.0410

This Viewpoint from US FDA Commissioner Robert Califf discusses existing agency decision support tools for assessing the benefits and risks of medical products under review and the advantages of harmonizing the currently separate frameworks used for evaluating devices and for drugs and biologics.

January 19, 2017
Viewpoint

Surviving Sepsis GuidelinesA Continuous Move Toward Better Care of Patients With Sepsis

Abstract Full Text
free access
JAMA. Published online January 19, 2017. doi:10.1001/jama.2017.0059

This Viewpoint describes the history of the Surviving Sepsis Campaign (SSC), the rationale for and results of the January 2017 fourth revision to the Surviving Sepsis Guidelines, and future directions for the SSC.

JAMA Clinical Guidelines Synopsis

Management of Sepsis and Septic Shock

Abstract Full Text
free access
JAMA. Published online January 19, 2017. doi:10.1001/jama.2017.0131

This JAMA Clinical Guidelines Synopsis summarizes the Surviving Sepsis Campaign’s, Society of Critical Care Medicine’s, and European Society of Intensive Care Medicine’s 2017 guideline on management of sepsis and septic shock.

Research Letter

Change in Distance to Nearest Facility and Abortion in Texas, 2012 to 2014

Abstract Full Text
free access
JAMA. Published online January 19, 2017. doi:10.1001/jama.2016.17026

This study uses data from the Texas Department of State Health Services to determine the association between change in distance to a facility that offers abortion after passage of a state law leading to closure of some facilities and percentage change in the number of abortions between 2012 and 2014.

Correction

Incorrect Values and Excluded Units of Measure

Abstract Full Text
free access
JAMA. Published online January 19, 2017. doi:10.1001/jama.2017.0013
January 12, 2017
Viewpoint

Emerging and Reemerging Infectious DiseasesThe Dichotomy Between Acute Outbreaks and Chronic Endemicity

Abstract Full Text
free access
JAMA. Published online January 12, 2017. doi:10.1001/jama.2016.21079

This Viewpoint discusses the importance of continuing infectious diseases research, even after outbreaks subside and disease progression becomes endemic.

January 9, 2017
Viewpoint

Population Health EquityRate and Burden, Race and Class

Abstract Full Text
free access
JAMA. Published online January 9, 2017. doi:10.1001/jama.2016.19435

Although US racial and ethnic minorities have higher rates of poor health because of health care inequities, more low-income white individuals are affected because of greater population numbers. This Viewpoint explains that efforts to improve poor outcomes would be more effective if strategies were not based on proportions of race.

January 5, 2017
Viewpoint

New “21st Century Cures” LegislationSpeed and Ease vs Science

Abstract Full Text
free access
JAMA. Published online January 5, 2017. doi:10.1001/jama.2016.20640

This Viewpoint discusses potential threats to public health that arise from provisions of the 2016 21st Century Cures Act that allow drug manufacturers to use surrogate measures of safety and that encourage the US Food and Drug Administration to emphasize speed over science in the drug approval process.

×